Drug Profile
Research programme: analgesics and neurodegenerative disorders therapies - Biogen/BSi
Alternative Names: BSi-Biogen Idec Research ProgramLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Biogen Idec; Johns Hopkins Brain Science Institute
- Developer Biogen; Johns Hopkins Brain Science Institute
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease; Multiple sclerosis; Neurodegenerative disorders; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Alzheimer's-disease in USA
- 16 Jul 2016 No recent reports of development identified for research development in Multiple-sclerosis in USA
- 16 Jul 2016 No recent reports of development identified for research development in Neurodegenerative-disorders in USA